| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.2 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |